News

Catch up on FDA decisions, critical trial results, and expert perspectives on endocrinology.

INO-3107 immunotherapy significantly reduces surgeries for recurrent respiratory papillomatosis.

These new, phase 2 findings on the use of topical bimiralisib suggest positive results among patients with actinic keratosis.

The Q3 recap for gastroenterology spotlights key FDA decisions, new AGA gastroparesis guidelines, and other top GI news and research.

Read about groundbreaking FDA decisions, exciting new heart failure research, and more.

This review explores the safety of oral JAK inhibitors in inflammatory skin conditions, with 43 real-world studies being highlighted.

The approval is supported by data from the INTEGUMENT-PED phase 3 trial, the INTEGUMENT-OLE long-term extension study, and a phase 1 pharmacokinetic study.

The Q3 recap for hepatology spotlights key FDA news, the withdrawal of OCA for PBC, and notable hepatic research from the past few months.

An audio recap of the top 5 stories in healthcare news from the week of 9/28-10/04.

This study highlighted tildrakizumab’s use in daily practice within a heterogeneous cohort of patients with psoriasis commonly affected by comorbid conditions.

Therapist Diana Guzman, LMHC, writes about attempting suicide despite counseling patients battling with suicidal ideation.

Recent research refutes the conception that most, if not all, coronary heart disease occurs without typical CVD risk factors.

New research reveals GLP-1 receptor agonists may protect the liver from alcohol damage while increasing blood alcohol levels, prompting further human studies.

Q3 2025 saw more research emerge in asthma therapeutics and management as well as rarer pulmonary diseases.

Yale researchers reveal how essential coenzyme A is imported into mitochondria, shedding light on its role in metabolic diseases and potential treatments.

This analysis assesses the positive predictive value of the ICD-10 code for vitiligo commonly used in electronic medical record-based research.

Researchers unveil Bobcat339, a targeted molecule that selectively eliminates pathogenic macrophages.

A study reveals that APOE e4 carriers with atrial fibrillation on Eliquis face increased intracranial hemorrhage risk, highlighting critical genetic implications.

Yale researchers demonstrate that hands-on culinary medicine training significantly boosts nutrition knowledge and confidence among medical residents, enhancing patient care.

Yale researchers reveal that 17 million U.S. adolescents and young adults qualify for GLP-1RA therapy, highlighting barriers to access and insurance coverage.

Emerging research highlights the critical link between sleep quality and cardiovascular health.

The Q3 recap for nephrology spotlights key FDA decisions, new KDIGO IgA nephropathy guidelines, and other top renal news and research.

This set of interviews collects perspectives from 11 leading clinicians in the heart failure field, cataloguing the biggest news from 2025.

Read about new AGA gastroparesis guidelines, GI FDA news, and more.

Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key dermatology updates from EADV.